Long‐term and perioperative outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with propensity score matching: a multi‐institutional Japanese study T Takahara, G Wakabayashi, T Beppu, A Aihara, K Hasegawa, N Gotohda, ... Journal of Hepato‐Biliary‐Pancreatic Sciences 22 (10), 721-727, 2015 | 286 | 2015 |
Identification of Pancreatic Cancer Stem Cells and Selective Toxicity of Chemotherapeutic Agents R Adikrisna, S Tanaka, S Muramatsu, A Aihara, D Ban, T Ochiai, T Irie, ... Gastroenterology, 2012 | 147 | 2012 |
The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma A Aihara, S Tanaka, M Yasen, S Matsumura, Y Mitsunori, A Murakata, ... Journal of hepatology 52 (1), 63-71, 2010 | 100 | 2010 |
Dominant expression of DCLK1 in human pancreatic cancer stem cells accelerates tumor invasion and metastasis H Ito, S Tanaka, Y Akiyama, S Shimada, R Adikrisna, S Matsumura, ... PLoS One 11 (1), e0146564, 2016 | 89 | 2016 |
A cell‐surface β‐hydroxylase is a biomarker and therapeutic target for hepatocellular carcinoma A Aihara, CK Huang, MJ Olsen, Q Lin, W Chung, Q Tang, X Dong, ... Hepatology 60 (4), 1302-1313, 2014 | 84 | 2014 |
Clinical presentation of obturator hernia and review of the literature K Igari, T Ochiai, A Aihara, Y Kumagai, M Iida, S Yamazaki Hernia 14, 409-413, 2010 | 81 | 2010 |
Visualization of stem cell features in human hepatocellular carcinoma reveals in vivo significance of tumor‐host interaction and clinical course S Muramatsu, S Tanaka, K Mogushi, R Adikrisna, A Aihara, D Ban, ... Hepatology 58 (1), 218-228, 2013 | 79 | 2013 |
Expression of Aurora B and alternative variant forms in hepatocellular carcinoma and adjacent tissue M Yasen, H Mizushima, K Mogushi, G Obulhasim, K Miyaguchi, K Inoue, ... Cancer science 100 (3), 472-480, 2009 | 62 | 2009 |
ARID2 modulates DNA damage response in human hepatocellular carcinoma cells A Oba, S Shimada, Y Akiyama, T Nishikawaji, K Mogushi, H Ito, ... Journal of hepatology 66 (5), 942-951, 2017 | 61 | 2017 |
The difficulty of laparoscopic liver resection D Ban, A Kudo, H Ito, Y Mitsunori, S Matsumura, A Aihara, T Ochiai, ... Updates in surgery 67, 123-128, 2015 | 60 | 2015 |
Importin-α1 as a novel prognostic target for hepatocellular carcinoma K Yoshitake, S Tanaka, K Mogushi, A Aihara, A Murakata, S Matsumura, ... Annals of surgical oncology 18, 2093-2103, 2011 | 60 | 2011 |
Aspartate β-hydroxylase expression promotes a malignant pancreatic cellular phenotype X Dong, Q Lin, A Aihara, Y Li, CK Huang, W Chung, Q Tang, X Chen, ... Oncotarget 6 (2), 1231, 2015 | 56 | 2015 |
LRH1 promotes pancreatic cancer metastasis Q Lin, A Aihara, W Chung, Y Li, X Chen, Z Huang, S Weng, RI Carlson, ... Cancer letters 350 (1-2), 15-24, 2014 | 51 | 2014 |
Upregulation of protein tyrosine phosphatase type IVA member 3 (PTP4A3/PRL-3) is associated with tumor differentiation and a poor prognosis in human hepatocellular carcinoma A Mayinuer, M Yasen, K Mogushi, G Obulhasim, M Xieraili, A Aihara, ... Annals of surgical oncology 20, 305-317, 2013 | 51 | 2013 |
Analogy between sphere forming ability and stemness of human hepatoma cells Y Uchida, S Tanaka, A Aihara, R Adikrisna, K Yoshitake, S Matsumura, ... Oncology reports 24 (5), 1147-1151, 2010 | 51 | 2010 |
LRH1 as a driving factor in pancreatic cancer growth Q Lin, A Aihara, W Chung, Y Li, Z Huang, X Chen, S Weng, RI Carlson, ... Cancer letters 345 (1), 85-90, 2014 | 49 | 2014 |
CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells E Katsuta, S Tanaka, K Mogushi, S Shimada, Y Akiyama, A Aihara, ... International journal of oncology 48 (2), 657-669, 2015 | 44 | 2015 |
Anti-tumor effects of second generation β-hydroxylase inhibitors on cholangiocarcinoma development and progression CK Huang, Y Iwagami, A Aihara, W Chung, S de la Monte, JM Thomas, ... PLoS One 11 (3), e0150336, 2016 | 42 | 2016 |
Contrast‐enhanced intraoperative ultrasonography for vascular imaging of hepatocellular carcinoma: Clinical and biological significance K Sato, S Tanaka, Y Mitsunori, K Mogushi, M Yasen, A Aihara, D Ban, ... Hepatology 57 (4), 1436-1447, 2013 | 39 | 2013 |
Acquired resistance with epigenetic alterations under long-term antiangiogenic therapy for hepatocellular carcinoma Y Ohata, S Shimada, Y Akiyama, K Mogushi, K Nakao, S Matsumura, ... Molecular cancer therapeutics 16 (6), 1155-1165, 2017 | 38 | 2017 |